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Abstract 
 Acetonitrile is easily displaced from [Fe2{µ-CN(Me)(R)}(µ-
CO)(CO)(MeCN)(Cp)2][SO3CF3] (R= 2,6-Me2C6H3 (Xyl), 1a; Me, 1b) upon stirring in THF at 
room temperature in the presence of [NBu4][SCN]. The resulting complexes trans-[Fe2{µ-
CN(Me)(R)}(µ-CO)(CO)(NCS)(Cp)2] (R= Xyl, trans-2a; Me, trans-2b) are completely 
isomerised to cis-[Fe2{µ-CN(Me)(R)}(µ-CO)(CO)(NCS)(Cp)2]  (R= Xyl, cis-2a; Me, cis-2b) 
when heated at reflux temperature. Similarly, the complexes cis-[M2{µ-CN(Me)(R)}(µ-
CO)(CO)(NCO)(Cp)2]  (M = Fe, R= Me, 4a; M = Ru, R = Xyl, 4b; M = Ru, R = Me, 4c) and cis-
[M2{µ-CN(Me)(R)}(µ-CO)(CO)(N3)(Cp)2]  (M = Fe, R= Xyl, 5a; M = Fe, R = Me, 5b; M = Ru, R 
= Xyl, 5c) can be obtained by heating at reflux temperature a THF solution of [M2{µ-
CN(Me)(R)}(µ-CO)(CO)(MeCN)(Cp)2][SO3CF3] (M = Fe, R= Xyl, 1a; M = Fe, Me, 1b; M = Ru, R 
= Xyl, 1c; M = Ru, R = Me, 1d) in the presence of NaNCO and NaN3, respectively. The reactions 
of 5 with MeO2CC≡CCO2Me, HC≡CCO2Me and (NC)(H)C=C(H)(CN) afford the triazolato 
complexes [M2{µ-CN(Me)(R)}(µ-CO)(CO){N3C2(CO2Me)2}(Cp)2] (M = Fe, R= Xyl, 6a; M = Fe, 
R = Me, 6b; M = Ru, R = Xyl, 6c), [M2{µ-CN(Me)(R)}(µ-CO)(CO){N3C2(H)(CO2Me)}(Cp)2] (M 
= Fe, R= Me, 7a; M = Ru, R = Xyl, 7b) and [Fe2{µ-CN(Me)(Xyl)}(µ-
CO)(CO){N3C2(H)(CN)}(Cp)2], 8, respectively. The asymmetrically substituted triazolato 
complexes 7-8 are obtained as mixtures of N(1) and N(2) bonded isomers, whereas 6 exist only in 
the N(2) form. Methylation of 6-8 results in the formation of the triazole complexes [Fe2{µ-
CN(Me)(Xyl)}(µ-CO)(CO){N3(Me)C2(CO2Me)2}(Cp)2][CF3SO3], 9, [M2{µ-CN(Me)(R)}(µ-
CO)(CO){N3(Me)C2(H)(CO2Me) }(Cp)2][CF3SO3] (M = Fe, R = Me, 10a; M = Ru, R = Xyl, 10b) 
and [Fe2{µ-CN(Me)(Xyl)}(µ-CO)(CO){N3(Me)C2(H)(CN)}(Cp)2][CF3SO3], 11. The crystal 
structures of trans-2b, 4b·CH2Cl2, 5a, 6b·0.5CH2Cl2 and 8·CH2Cl2 have been determined.  
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1. Introduction 
 
 Pseudohalides are quite versatile ligands, which can coordinate to the metals both terminally 
or in a bridging fashion [1, 2]. Moreover, when the two end-atoms are different, they can also 
display linkage isomerism. If the atoms belong to different periods (e.g NCS-, NCSe-), they usually 
coordinate through nitrogen to ‘class a’ and via sulfur or selenium to ‘class b’ metals [3]. 
Conversely, in the case of isocyanates, NCO-, coordination usually occurs via nitrogen, being O-
coordination quite rare [3c, 4, 5]. The coordinated pseudohalides behave as 1,3-dipoles and, 
therefore, can be used in order to prepare new ligands via 1,3-dipolar cycloaddition reactions [6, 7].  
 Herein, we report on the synthesis and reactivity of diiron and diruthenium aminocarbyne 
complexes containing terminal pseudohalides. This work is part of our ongoing interest in the study 
of the formation of new C-C and C-N bonds in bimetallic species [8-10], with particular attention to 
the possibility of selectively addressing the reactions on terminal or bridging ligands and promoting 
their coupling.  
 
2. Experimental 
 
All reactions were carried out routinely under nitrogen using standard Schlenk techniques. 
Solvents were distilled immediately before use under nitrogen from appropriate drying agents. 
Infrared spectra were recorded on a Perkin-Elmer Spectrum 2000 FT-IR spectrophotometer and 
elemental analyses were performed on a ThermoQuest Flash 1112 Series EA Instrument. ESI MS 
spectra were recorded on a Waters Micromass ZQ 4000 with samples dissolved in CH3CN. All 
NMR measurements were performed on Varian Gemini 300 and Mercury Plus 400 instruments. The 
chemical shifts for 1H and 13C were referenced to internal TMS. The spectra were fully assigned via 
DEPT experiments and 1H,13C correlation measured using gs-HSQC and gs-HMBC experiments 
[11]. NOE measurements were recorded using the DPFGSE-NOE sequence [12]. All chemicals 
were used as received from Aldrich Co., except [Fe2{µ-CN(Me)(R)}(µ-
CO)(CO)(MeCN)(Cp)2][SO3CF3] (R= 2,6-Me2C6H3 (Xyl), 1a; Me, 1b) and [Ru2{µ-CN(Me)(R)}(µ-
CO)(CO)(MeCN)(Cp)2][SO3CF3] (R= Xyl, 1c; Me, 1d) [9b] which were prepared by published 
methods.  
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2.1 Synthesis of trans-[Fe2{µ-CN(Me)(R)}(µ-CO)(CO)(NCS)(Cp)2] (R= Xyl, trans-2a; Me, trans-
2b).  
[NBu4][SCN] (129 mg, 0.430 mmol) was added to a CH2Cl2 (6 ml) solution of [Fe2{µ-
CN(Me)(R)}(µ-CO)(CO)(NCMe)(Cp)2][CF3SO3] (0.147 mmol), and the mixture was stirred at 
room temperature for 3 hours. The solvent was, then, removed under reduced pressure and the 
residue was chromatographed through alumina. A fraction containing trans-[Fe2{µ-CN(Me)(R)}(µ-
CO)(CO)(NCS)(Cp)2] was obtained using CH2Cl2 as eluent.  
trans-2a Yield 52.4 mg (71 %). Anal. Calcd. For C23H22Fe2N2O2S: C, 55.01; H, 4.42; N, 5.58. 
Found: C, 55.32; H, 4.12; N, 5.76. IR (CH2Cl2, 293 K): ν(NCS) 2112 (vs); ν(CO) 1968 (vs), 1812 
(s); ν(µ-CN) 1549 (w) cm-1. 1H NMR (CDCl3, 293 K): δ 7.42-7.29 (m, 3H, Me2C6H3), 4.93 (s, 3H, 
NMe), 4.76, 4.38 (s, 10H, Cp), 2.57, 2.41 (s, 6H, Me2C6H3).
 13C{1H} NMR (CDCl3, 293 K): δ 345.5 
(µ-CN), 262.6 (µ-CO), 212.5 (CO), 148.7 (Cipso Xyl), 140.6 (NCS), 134.0, 132.4 (C-Me Xyl), 
129.5, 129.3, 128.5 (CH Xyl), 88.9, 87.7 (Cp), 53.6 (NMe), 18.7, 18.4 (Me2C6H3).  
trans-2b Yield 46.0 mg (76 %). Anal. Calcd. For C16H16Fe2N2O2S: C, 46.63; H, 3.91; N, 6.80. 
Found: C, 46.87; H, 3.72; N, 6.98. IR (CH2Cl2, 293 K): ν(NCS) 2115 (vs); ν(CO) 1969 (vs), 1809 
(s); ν(µ-CN) 1568 (w) cm-1. 1H NMR (CDCl3, 293 K): δ 4.87, 4.58 (s, 10H, Cp), 4.71, 4.31 (s, 6H, 
NMe2).
 13C{1H} NMR (CDCl3, 293 K): δ 340.6 (µ-CN), 263.1 (µ-CO), 211.7 (CO), 140.8 (NCS), 
88.9, 87.4 (Cp), 52.5, 51.6 (NMe2).  
 
2.2 Synthesis of cis-[Fe2{µ-CN(Me)(R)}(µ-CO)(CO)(NCS)(Cp)2] (R= Xyl, cis-2a; Me, cis-2b).  
A solution of trans-[Fe2{µ-CN(Me)(R)}(µ-CO)(CO)(NCS)(Cp)2] (0.120 mmol) in THF (10 ml) 
was heated at reflux temperature for 5 hours. The solvent was, then, removed under reduced 
pressure and the residue was chromatographed through alumina. The final product cis-[Fe2{µ-
CN(Me)(R)}(µ-CO)(CO)(NCS)(Cp)2]  was obtained using THF as eluent.  
cis-2a Yield 56.0 mg (93 %). Anal. Calcd. For C23H22Fe2N2O2S: C, 55.01; H, 4.42; N, 5.58. Found: 
C, 55.32; H, 4.12; N, 5.76. IR (CH2Cl2, 293 K): ν(NCS) 2112 (vs); ν(CO) 1989 (vs), 1810 (s); ν(µ-
CN) 1507 (w) cm-1. 1H NMR (CDCl3, 293 K): δ 7.42-7.25 (m, 3H, Me2C6H3), 4.79, 4.17 (s, 10H, 
Cp), 4.84 (s, 3H, NMe), 2.68, 2.27 (s, 6H, Me2C6H3).
 13C{1H} NMR (CDCl3, 293 K): δ 341.4 (µ-
CN), 265.4 (µ-CO), 211.5 (CO), 148.1 (Cipso Xyl), 140.7 (NCS), 135.3-128.2 (C-Me + CH Xyl), 
87.3, 86.2 (Cp), 53.9 (NMe), 18.5, 17.6 (Me2C6H3).  
cis-2b Yield 39.6 mg (80 %). Anal. Calcd. For C16H16Fe2N2O2S: C, 46.63; H, 3.91; N, 6.80. Found: 
C, 46.87; H, 3.72; N, 6.98. IR (CH2Cl2, 293 K): ν(NCS) 2112 (vs); ν(CO) 1987 (vs), 1809 (s); ν(µ-
CN) 1579 (w) cm-1. 1H NMR (CDCl3, 293 K): δ 4.74, 4.62 (s, 10H, Cp), 4.44, 4.13 (s, 6H, NMe2).  
 
 4 
2.3 Synthesis of cis-[Fe2{µ-CN(Me)(Xyl)}(µ-CO)(CO)(NCSMe)(Cp)2][CF3SO3] (3).  
A solution of cis-[Fe2{µ-CN(Me)(Xyl)}(µ-CO)(CO)(NCS)(Cp)2] (131 mg, 0.260 mmol) in CH2Cl2 
(8 mL) was treated with CF3SO3Me (0.030 mL, 0.26 mmol), and the solution stirred for 30 minutes 
at room temperature. Then, the mixture was filtered on a celite pad, and the solvent was removed 
under reduced pressure. The residue was washed with diethyl ether (2 x 10 mL), yielding a brown 
powder.  
cis-3 Yield 150.0 mg (87 %). Anal. Calcd. For C25H25F3Fe2N2O5S2: C, 45.07; H, 3.78; N, 4.20. 
Found: C, 45.15; H, 3.81; N, 4.10. IR (CH2Cl2, 293 K): ν(CO) 1989 (vs), 1810 (s); ν(µ-CN) 1507 
(w) cm-1. 1H NMR (CDCl3, 293 K) Isomer α: δ 7.42-7.29 (m, 3H, Me2C6H3), 5.04, 4.51 (s, 10H, 
Cp), 4.79 (s, 3H, NMe), 2.70, 2.13 (s, 6H, Me2C6H3), 2.42 (s, 3H, SMe); Isomer β: δ 7.42-7.29 (m, 
3H, Me2C6H3), 5.17, 4.34 (s, 10H, Cp), 4.50 (s, 3H, NMe), 2.71, 2.07 (s, 6H, Me2C6H3), 2.35 (s, 
3H, SMe). Isomer ratio = 2. 13C{1H} NMR (CDCl3, 293 K) Isomer α: δ 337.2 (µ-C), 263.4 (µ-CO), 
210.9 (CO), 147.9 (Cipso Xyl), 133.1, 132.0, 129.9, 129.1, 128.9 (C-Me + CH Xyl), 124.1 (NCS), 
88.1, 87.7 (Cp), 54.2 (NMe), 18.7, 17.4 (Me2C6H3), 16.7 (SMe); Isomer β: 336.5 (µ-C), 264.1 (µ-
CO), 210.4 (CO), 148.0 (Cipso Xyl), 133.5, 132.4, 129.8, 129.0 (C-Me + CH Xyl), 123.7 (NCS), 
89.1, 86.8 (Cp), 55.2 (NMe), 18.9, 17.8, (Me2C6H3), 16.6 (SMe). ESI-MS (ES
+): 517 (M+, 65%), 
444 (M+-NCSMe, 100%) m/z. 
 
2.4 Synthesis of [M2{µ-CN(Me)(R)}(µ-CO)(CO)(NCO)(Cp)2] (M= Fe, R= Me, 4a; M= Ru R= Xyl, 
4b; M= Ru, R= Me, 4c).  
NaNCO (500 mg, 7.69 mmol) was added to a solution of [M2{CN(Me)(R)}(µ-
CO)(CO)(CH3CN)(Cp)2][TfO] (0.230 mmol) in THF (15 ml), and the resulting suspension was 
heated at reflux temperature for 3 hours. Hence, the solvent was removed in vacuo and the residue 
dissolved in CH2Cl2 and chromatographed through Al2O3. A fraction corresponding to the final 
product [M2{µ-CN(Me)(R)}(µ-CO)(CO)(NCO)(Cp)2] was obtained using MeCN as eluent.  
4a Yield 69.2 mg (76 %). Anal. Calcd. For C16H16Fe2N2O3: C, 48.52; H, 4.07; N, 7.08. Found: C, 
48.23; H, 4.21; N, 6.89. IR (CH2Cl2, 293 K): ν(NCO) 2237 (vs); ν(CO) 1980 (vs), 1803 (m) cm-1. 
1H NMR (CDCl3, 293 K): δ  4.77, 4.63 (s, 10H, Cp), 4.64, 4.23 (s, 6H, NMe2). 
4b Yield 104.7 mg (79 %). Anal. Calcd. For C23H22N2O3Ru2: C, 47.91; H, 3.85; N, 4.86. Found: C, 
47.46; H, 3.99; N, 4.65. IR (CH2Cl2, 293 K): ν(NCO) 2236 (s); ν(CO) 1978 (vs), 1802 (s); ν(µ-CN) 
1519 (m) cm-1. 1H NMR (CDCl3, 293 K): δ 7.29-7.19 (m, 3H, Me2C6H3), 5.16, 4.84 (s, 10H, Cp), 
4.25 (s, 3H, NMe), 2.40, 2.29 (s, 6H, Me2C6H3).
 13C{1H} NMR (CDCl3, 293 K): δ 313.1 (µ-CN), 
235.8 (µ-CO), 200.1 (CO), 147.9 (Cipso Xyl), 133.7, 132.6 (C-Me Xyl), 129.9, 128.4, 128.1 (CH 
Xyl), 128.9 (NCO), 88.5, 87.5 (Cp), 51.5 (NMe), 18.3, 17.5 (Me2C6H3).  
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4c Yield 92.7 mg (83 %). Anal. Calcd. For C16H16N2O3Ru2: C, 39.51; H, 3.32; N, 5.76. Found: C, 
39.89; H, 3.68; N, 5.91. IR (CH2Cl2, 293 K): ν(NCO) 2237 (s); ν(CO) 1977 (vs), 1802 (s); ν(µ-CN) 
1589 (m), 1564 (ms) cm-1. 1H NMR (CDCl3, 293 K): δ 5.20, 5.02 (s, 10H, Cp), 4.02, 3.98 (s, 6H, 
NMe2).
 13C{1H} NMR (CDCl3, 293 K): δ 307.0 (µ-CN), 236.2 (µ-CO), 199.3 (CO), 127.2 (NCO), 
88.5, 87.1 (Cp), 52.4, 51.1 (NMe2).  
 
2.5 Synthesis of [M2{µ-CN(Me)(R)}(µ-CO)(CO)(N3)(Cp)2] (M= Fe, R= Xyl, 5a; M= Fe R= Me, 5b; 
M= Ru, R= Xyl, 5c).  
NaN3 (500 mg, 7.69 mmol) was added to a solution of [M2{CN(Me)(R)}(µ-
CO)(CO)(CH3CN)(Cp)2][TfO] (0.230 mmol) in THF (15 ml), and the resulting suspension was 
heated at reflux temperature for 3 hours. Hence, the solvent was removed in vacuo and the residue 
dissolved in CH2Cl2 and chromatographed through Al2O3. The product [M2{µ-CN(Me)(R)}(µ-
CO)(CO)(NCO)(Cp)2] was obtained using THF as eluent.  
5a Yield 78.7 mg (70 %). Anal. Calcd. For C22H22Fe2N4O2: C, 54.36; H, 4.56; N, 11.52. Found: C, 
54.57; H, 4.01; N, 11.23. IR (CH2Cl2, 293 K): ν(N3) 2033 (vs); ν(CO) 1980 (s), 1800 (br) cm-1. 1H 
NMR (CDCl3, 293 K) Isomer α: δ 7.40-7.26 (m, 3H, Me2C6H3), 4.87 (s, 3H, NMe), 4.80, 4.30 (s, 
10H, Cp), 2.71, 2.23 (s, 6H, Me2C6H3); Isomer β: δ 7.40-7.26 (m, 3H, Me2C6H3), 5.04 (s, 3H, 
NMe), 4.85, 4.21 (s, 10H, Cp), 2.61, 2.42 (s, 6H, Me2C6H3). α/β= 10. 
13C{1H} NMR (CDCl3, 293 
K) Isomer α: δ 342.5 (µ-CN), 266.1 (µ-CO), 211.3 (CO), 148.4-128.5 (Xyl), 86.6 (Cp), 52.3 
(NMe), 18.6, 17.6 (Me2C6H3); Isomer β: 86.5 (Cp), 52.4 (NMe).  
5b Yield 59.2 mg (65 %). Anal. Calcd. For C15H16Fe2N4O2: C, 45.49; H, 4.07; N, 14.15. Found: C, 
45.11; H, 4.23; N, 14.45. IR (CH2Cl2, 293 K): ν(N3) 2030 (vs); ν(CO) 1976 (vs), 1806 (s); ν(µ-CN) 
1578 (m) cm-1. 1H NMR (CDCl3, 293 K): δ 4.74, 4.63 (s, 10H, Cp), 4.66, 4.24 (s, 6H, NMe2). 
13C{1H} NMR (CDCl3, 293 K): δ 89.1, 86.6 (Cp), 52.8, 51.6 (NMe2).  
5c Yield 99.5 mg (75 %). Anal. Calcd. For C22H22N4O2Ru2: C, 45.83; H, 3.85; N, 9.72. Found: C, 
46.15; H, 3.61; N, 9.91. IR (CH2Cl2, 293 K): ν(N3) 2033 (vs); ν(CO) 1974 (s), 1800 (s); ν(µ-CN) 
1512 (m) cm-1. 1H NMR (CDCl3, 293 K): δ 7.29-7.20 (m, 3H, Me2C6H3), 5.21, 4.83 (s, 10H, Cp), 
4.30 (s, 3H, NMe), 2.39, 2.32 (s, 6H, Me2C6H3). 
13C{1H} NMR (CDCl3, 293 K): δ 312.1 (µ-CN), 
237.0 (µ-CO), 200.3 (CO), 147.9 (Cipso Xyl), 133.7, 132.6 (C-Me Xyl), 129.7, 128.3, 128.0 (CH 
Xyl), 88.5, 87.8 (Cp), 51.3 (NMe), 18.2, 17.5 (Me2C6H3).  
 
2.6 Synthesis of [M2{µ-CN(Me)(R)}(µ-CO)(CO){N3C2(CO2Me)2}(Cp)2] (M= Fe, R= Xyl, 6a; M= 
Fe R= Me, 6b; M= Ru, R= Xyl, 6c).  
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A solution containing [M2{µ-CN(Me)(R)}(µ-CO)(CO)(N3)(Cp)2] (0.411 mmol) and 
MeO2CC≡CCO2Me (0.2 ml, 1.63 mmol) in THF (15 ml) was heated at reflux temperature for 3 
hours and, then, the solvent was removed under reduced pressure. Hence, the residue was washed 
with petroleum ether (2x20 ml), dissolved in CH2Cl2 and chromatographed through Al2O3. The 
final product was obtained as an orange-brown fraction using THF as eluent.  
6a Yield 206.6 mg (70 %). Anal. Calcd. For C28H28Fe2N4O6: C, 53.53; H, 4.49; N, 8.92. Found: C, 
53.89; H, 4.06; N, 8.68. IR (CH2Cl2, 293 K): ν(CO) 1985 (vs), 1806 (s); ν(CO2Me) 1734 (s); ν(µ-
CN) 1507 (m) cm-1. 1H NMR (CDCl3, 293 K): δ 7.31-7.23 (m, 3H, Me2C6H3), 4.96 (s, 3H, NMe), 
4.85, 4.28 (s, 10H, Cp), 3.72 (s, 6H, CO2Me), 2.68, 2.15 (s, 6H, Me2C6H3). 
13C{1H} NMR (CDCl3, 
293 K): δ 340.4 (µ-CN), 265.9 (µ-CO), 210.6 (CO), 162.1 (CO2Me), 148.9 (Cipso Xyl), 140.5 
(N3C2), 134.8, 132.6 (C-Me Xyl), 130.2, 128.3, 128.1 (CH Xyl), 87.3, 86.9 (Cp), 53.2 (NMe), 51.5 
(CO2Me), 18.6, 17.1 (Me2C6H3).  
6b Yield 168.1 mg (76 %). Anal. Calcd. For C21H22Fe2N4O6: C, 46.87; H, 4.12; N, 10.41. Found: C, 
47.05; H, 3.98; N, 10.07. IR (CH2Cl2, 293 K): ν(CO) 1983 (vs), 1806 (s); ν(CO2Me) 1727 (s); ν(µ-
CN) 1577 (w), 1551 (m) cm-1. 1H NMR (CDCl3, 293 K): δ 4.73, 4.71 (s, 10H, Cp), 4.68, 4.11 (s, 
6H, NMe2), 3.69 (s, 6H, CO2Me).
 13C{1H} NMR (CDCl3, 293 K): δ 334.3 (µ-CN), 265.9 (µ-CO), 
210.0 (CO), 162.1 (CO2Me), 140.2 (N3C2), 87.0, 86.9 (Cp), 53.3, 52.2 (NMe2), 51.6 (CO2Me).  
6c Yield 254.4 mg (86 %). Anal. Calcd. For C28H28N4O6Ru2: C, 46.79; H, 3.93; N, 7.80. Found: C, 
46.24; H, 4.11; N, 7.99. IR (CH2Cl2, 293 K): ν(CO) 1979 (vs), 1804 (s); ν(CO2Me) 1738 (sh), 1713 
(vs); ν(µ-CN) 1519 (m) cm-1. 1H NMR (CDCl3, 293 K): δ 7.31-7.20 (m, 3H, Me2C6H3), 5.33, 4.85 
(s, 10H, Cp), 4.44 (s, 3H, NMe), 3.83 (s, 6H, CO2Me), 2.44, 2.22 (s, 6H, Me2C6H3). 
13C{1H} NMR 
(CDCl3, 293 K): δ 311.4 (µ-CN), 236.3 (µ-CO), 199.0 (CO), 162.2 (CO2Me), 148.3 (Cipso Xyl), 
139.7 (N3C2), 134.3, 132.3 (C-Me Xyl), 129.9, 128.2, 127.7 (CH Xyl), 88.6, 88.1 (Cp), 52.1 (NMe), 
51.6 (CO2Me), 18.4, 17.1 (Me2C6H3).  
 
2.7 Synthesis of [M2{µ-CN(Me)(R)}(µ-CO)(CO){N3C2(H)(CO2Me)}(Cp)2] (M= Fe, R= Me, 7a; M= 
Ru, R= Xyl, 7b).  
A solution containing [M2{µ-CN(Me)(R)}(µ-CO)(CO)(N3)(Cp)2] (0.240 mmol) and HC≡CCO2Me 
(0.1 ml, 1.12 mmol) in THF (15 ml) was heated at reflux temperature for 3 hours and, then, the 
solvent was removed under reduced pressure. Hence, the residue was washed with petroleum ether 
(2x20 ml), dissolved in CH2Cl2 and chromatographed through Al2O3. The final product was 
obtained as an orange-brown fraction using THF as eluent.  
7a Yield 93.5 mg (81 %). Anal. Calcd. For C19H20Fe2N4O4: C, 47.53; H, 4.20; N, 11.67. Found: C, 
47.86; H, 4.01; N, 11.12. IR (CH2Cl2, 293 K): ν(CO) 1982 (vs), 1805 (s); ν(CO2Me) 1721 (s); ν(µ-
 7 
CN) 1576 (ms), 1505 (w) cm-1. 1H NMR (CDCl3, 293 K) Major isomer: δ 7.56 (s, 1H, CH), 4.82, 
4.78 (s, 10H, Cp), 4.70, 4.21 (s, 6H, NMe2), 3.73 (s, 3H, CO2Me); Minor isomer: δ 7.72 (s, 1H, 
CH), 4.91, 4.81 (s, 10H, Cp), 4.70, 4.21 (s, 6H, NMe2), 3.76 (s, 3H, CO2Me). Major/Minor = 2.
 
13C{1H} NMR (CDCl3, 293 K) Major isomer: δ 334.3 (µ-CN), 266.6 (µ-CO), 210.3 (CO), 162.4 
(CO2Me), 138.2 (N3CHCCO2Me), 137.6 (CH), 87.0, 86.9 (Cp), 53.2, 52.2 (NMe2), 50.8 (CO2Me); 
Minor isomer: δ 332.5 (µ-CN), 270.7 (µ-CO), 209.6 (CO), 162.2 (CO2Me), 139.7 (N3CHCCO2Me), 
139.4 (CH), 87.1, 86.7 (Cp), 53.5, 52.8 (NMe2), 50.9 (CO2Me).  
7b Yield 128.7 mg (81 %). Anal. Calcd. For C26H26N4O4Ru2: C, 47.27; H, 3.97; N, 8.48. Found: C, 
47.65; H, 3.68; N, 8.89. IR (CH2Cl2, 293 K): ν(CO) 1978 (s), 1803 (s); ν(CO2Me) 1712 (s); ν(µ-
CN) 1520 (ms), 1505 (w) cm-1. 1H NMR (CDCl3, 293 K) Major isomer: δ 7.86 (s, 1H, CH), 7.27-
7.22 (m, 3H, Me2C6H3), 5.25, 4.86 (s, 10H, Cp), 4.52 (s, 3H, NMe), 3.83 (s, 3H, CO2Me), 2.46, 2.18 
(s, 6H, Me2C6H3); Minor isomer: δ 7.79 (s, 1H, CH), 7.27-7.22 (m, 3H, Me2C6H3), 5.33, 4.86 (s, 
10H, Cp), 4.48 (s, 3H, NMe), 3.79 (s, 3H, CO2Me), 2.46, 2.19 (s, 6H, Me2C6H3). Major/Minor = 2.
 
13C{1H} NMR (CDCl3, 293 K) Major isomer: δ 310.7 (µ-CN), 240.1 (µ-CO), 199.1 (CO), 162.9 
(CO2Me), 148.5 (Cipso Xyl), 139.5 (CH), 137.3 (N3CHCCO2Me), 134.5, 132.3 (C-Me Xyl), 130.0-
127.8 (CH Xyl), 88.7, 88.0 (Cp), 52.5 (NMe), 51.0 (CO2Me), 18.3, 17.3 (Me2C6H3); Minor isomer: 
δ 311.9 (µ-CN), 237.3 (µ-CO), 199.5 (CO), 162.8 (CO2Me), 148.5 (Cipso Xyl), 139.4 (CH), 138.1 
(N3CHCCO2Me), 134.5, 132.5 (C-Me Xyl), 130.0-127.8 (CH Xyl), 88.6, 88.2 (Cp), 52.0 (NMe), 
51.0 (CO2Me), 18.3, 16.9 (Me2C6H3).  
 
2.8 Synthesis of [Fe2{µ-CN(Me)(Xyl)}(µ-CO)(CO){N3C2(H)(CN)}(Cp)2], 8.  
A solution containing [Fe2{µ-CN(Me)(Xyl)}(µ-CO)(CO)(N3)(Cp)2] (75.1 mg, 0.154 mmol) and 
(NC)(H)C≡C(H)(CN) (34.1 mg, 0.437 mmol) in THF (6 ml) was heated at reflux temperature for 5 
hours and, then, the solvent was removed under reduced pressure. Hence, the residue was washed 
with petroleum ether (2x20 ml), dissolved in CH2Cl2 and chromatographed through Al2O3. The 
final product was obtained as an orange-brown fraction using THF as eluent.  
8 Yield 67.8 mg (82 %). Anal. Calcd. For C25H23Fe2N5O2: C, 55.90; H, 4.32; N, 13.04. Found: C, 
55.59; H, 4.54; N, 13.15. IR (CH2Cl2, 293 K): ν(CN) 2232 (ms); ν(CO) 1986 (vs), 1805 (s); ν(µ-
CN) 1509 (ms), 1505 (w) cm-1. 1H NMR (CDCl3, 293 K) Major isomer: δ 7.74 (s, 1H, CH), 7.31-
7.21 (m, 3H, Me2C6H3), 5.11 (s, 3H, NMe), 4.74, 4.29 (s, 10H, Cp), 2.69, 2.03 (s, 6H, Me2C6H3); 
Minor isomer: δ 7.46 (s, 1H, CH), 7.31-7.21 (m, 3H, Me2C6H3), 4.96 (s, 3H, NMe), 4.81, 4.28 (s, 
10H, Cp), 2.68, 2.08 (s, 6H, Me2C6H3). Major/Minor = 1.1.
 13C{1H} NMR (CDCl3, 293 K) Major 
isomer: δ 339.2 (µ-CN), 270.9 (µ-CO), 210.1 (CO), 148.9 (Cipso Xyl), 140.9 (CH), 134.5, 132.4 
(C-Me Xyl), 130.4-128.2 (CH Xyl), 118.5 (CN), 114.4 (N3CHCCN), 87.2, 86.9 (Cp), 53.9 (NMe), 
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18.6, 17.2 (Me2C6H3); Minor isomer: δ 340.9 (µ-CN), 266.7 (µ-CO), 210.8 (CO), 149.0 (Cipso 
Xyl), 139.2 (CH), 134.5, 132.6 (C-Me Xyl), 130.4-128.2 (CH Xyl), 119.4 (CN), 114.5 
(N3CHCCN), 87.3, 86.0 (Cp), 53.1 (NMe), 18.6, 16.9 (Me2C6H3).  
 
2.9 Synthesis of [Fe2{µ-CN(Me)(Xyl)}(µ-CO)(CO){N3(Me)C2(CO2Me)2}(Cp)2][CF3SO3], 9.  
CF3SO3Me (0.1 ml, 0.884 mmol) was added to a solution of 6a (200.0 mg, 0.279 mmol) in CH2Cl2 
(6 ml); after stirring at room temperature for 30 minutes, the solvent was removed under reduced 
pressure and the residue washed with Et2O (2x10 ml).  
9 Yield 222.6 mg (92 %). Anal. Calcd. For C30H31F3Fe2N4O9S: C, 41.55; H, 3.60; N, 6.46. Found: 
C, 41.92; H, 3.47; N, 6.31. IR (CH2Cl2, 293 K): ν(CO) 1982 (vs), 1808 (s); ν(CO2Me) 1745 (s) cm-
1. 1H NMR (CDCl3, 293 K): δ 7.25 (m, 3H, Me2C6H3), 5.06 (s, 3H, NMe), 4.90, 4.28 (s, 10H, Cp), 
3.98 (s, 3H, N3Me), 3.80 (s, 6H, CO2Me), 2.62, 2.15 (s, 6H, Me2C6H3). 
13C{1H} NMR (CDCl3, 293 
K): δ 330.4 (µ-CN), 266.9 (µ-CO), 210.7 (CO), 155.8 (CO2Me), 148.9 (Cipso Xyl), 133.6, 132.8, 
132.7 (C-Me Xyl + N3C2), 130.0, 128.8, 128.7 (CH Xyl), 88.3, 87.2 (Cp), 54.6, 53.7 (NMe + 
CO2Me), 39.5 (N3Me), 18.7, 16.9 (Me2C6H3).  
 
2.10 Synthesis of [M2{µ-CN(Me)(R)}(µ-CO)(CO){N3(Me)C2(H)(CO2Me)}(Cp)2][CF3SO3] (M = Fe, 
R = Me, 10a; M = Ru, R = Xyl, 10b).  
CF3SO3Me (0.1 ml, 0.884 mmol) was added to a solution of 7 (0.300 mmol) in CH2Cl2 (6 ml); after 
stirring at room temperature for 30 minutes, the solvent was removed under reduced pressure and 
the residue washed with Et2O (2x10 ml).  
10a Yield 172.0 mg (89 %). Anal. Calcd. For C21H23F3Fe2N4O7S: C, 39.15; H, 3.60; N, 8.70. 
Found: C, 39.03; H, 3.82; N, 8.46. IR (CH2Cl2, 293 K): ν(CO) 1983 (vs), 1799 (s); ν(CO2Me) 1742 
(m), 1718 (m); ν(µ-CN) 1581 (m) cm-1. 1H NMR (CDCl3, 293 K): δ 8.03 (s, 1H, CH), 4.96, 4.79 (s, 
10H, Cp), 4.82, 4.30 (s, 6H, NMe2), 4.03 (s, 3H, N3Me), 3.84 (s, 3H, CO2Me).
  
10b Yield 235.0 mg (95 %). Anal. Calcd. For C28H29F3N4O7Ru2S: C, 40.78; H, 3.54; N, 6.80. 
Found: C, 40.46; H, 3.74; N, 7.01. IR (CH2Cl2, 293 K): ν(CO) 1978 (vs), 1806 (s); ν(CO2Me) 1746 
(s); ν(µ-CN) 1528 (ms) cm-1. 1H NMR (CDCl3, 293 K): δ 8.14 (s, 1H, CH), 7.24-7.21 (m, 3H, 
Me2C6H3), 5.34, 4.89 (s, 10H, Cp), 4.36 (s, 3H, NMe), 4.19 (s, 3H, N3Me), 3.90 (s, 3H, CO2Me), 
2.41, 2.19 (s, 6H, Me2C6H3).
 13C{1H} NMR (CDCl3, 293 K): δ 310.8 (µ-CN), 240.0 (µ-CO), 200.3 
(CO), 156.9 (CO2Me), 148.2 (Cipso Xyl), 143.5 (CH), 130.0, 132.6 (C-Me Xyl), 129.9 
(N3CHCCO2Me), 129.8, 128.8, 128.7 (CH Xyl), 89.6, 88.3 (Cp), 53.3 (NMe), 53.1 (CO2Me), 38.7 
(N3Me), 18.4, 16.9 (Me2C6H3).  
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2.11 Synthesis of [Fe2{µ-CN(Me)(Xyl)}(µ-CO)(CO){N3(Me)C2(H)(CN)}(Cp)2][CF3SO3], 11.  
CF3SO3Me (0.1 ml, 0.884 mmol) was added to a solution of 8 (190.0 mg, 0.354 mmol) in CH2Cl2 
(6 ml); after stirring at room temperature for 30 minutes, the solvent was removed under reduced 
pressure and the residue washed with Et2O (2x10 ml).  
11 Yield 223.5 mg (92 %). Anal. Calcd. For C27H26F3Fe2N5O5S: C, 47.26; H, 3.82; N, 10.21. 
Found: C, 47.62; H, 3.67; N, 10.45. IR (CH2Cl2, 293 K): ν(CN) 2220 (m), ν(CO) 1986 (vs), 1818 
(s); ν(µ-CN) 1522 (m) cm-1. 1H NMR (CDCl3, 293 K) Major isomer: δ 9.13 (s, 1H, CH), 7.30 (m, 
3H, Me2C6H3), 4.19 (s, 3H, NMe), 5.07, 4.50 (s, 10H, Cp), 3.85 (s, 3H, N3Me), 2.69, 2.03 (s, 6H, 
Me2C6H3); Minor isomer: δ 8.37 (s, 1H, CH), 7.30 (m, 3H, Me2C6H3), 5.14 (s, 3H, NMe), 4.98, 4.38 
(s, 10H, Cp), 4.34 (s, 3H, N3Me), 2.66, 2.11 (s, 6H, Me2C6H3). Major/Minor = 1.2.
 13C{1H} NMR 
(CDCl3, 293 K) Major isomer: δ 336.1 (µ-CN), 265.6 (µ-CO), 210.7 (CO), 148.3 (Cipso Xyl), 
134.8, 132.6 (C-Me Xyl), 132.3 (N3CHCCN), 130.1-128.8 (CH Xyl), 118.7 (CH), 117.7 (CN), 
88.2, 86.8 (Cp), 54.2 (NMe), 41.0 (N3Me), 18.3, 17.0 (Me2C6H3); Minor isomer: δ 338.3 (µ-CN), 
261.7 (µ-CO), 210.7 (CO), 147.7 (Cipso Xyl), 136.7, 132.8 (C-Me Xyl), 131.8 (N3CHCCN), 130.1-
128.8 (CH Xyl), 119.2 (CH), 116.8 (CN), 88.3, 88.2 (Cp), 54.0 (NMe), 40.3 (N3Me), 18.5, 16.9 
(Me2C6H3).  
 
2.12 Crystallography 
Compounds trans-2b, 4b·CH2Cl2, 5a, 6b·0.5CH2Cl2 and 8·CH2Cl2 were crystallized from 
CH2Cl2/ petroleum ether at –20 ºC. Crystal data were collected on a Bruker AXS SMART 2000 
CCD diffractometer using Mo-Kα radiation. Intensity data were measured over full diffraction 
spheres using 0.3° wide ω scans, crystal-to-detector distance 5.2 cm. Cell dimensions and 
orientation matrixes were initially determined from least-squares refinements on reflections 
measured in 3 sets of 20 exposures collected in three different ω regions and eventually refined 
against all reflections. The software SMART [13] was used for collecting frames of data, indexing 
reflections and determinations of lattice parameters. The collected frames were then processed for 
integration by the software SAINT and empirical absorption corrections were applied with 
SADABS [14]. The structure was solved by direct methods and refined by full-matrix least-squares 
based on all data using F2 [15]. Crystal data are listed in Table 1. Non-H atoms were refined 
anisotropically, unless otherwise stated. H-atoms were placed in calculated positions, and treated 
isotropically using the 1.2 fold Uiso value of the parent atom except methyl protons, which were 
assigned the 1.5 fold Uiso value of the parent C-atoms. One Cp ligand in trans-3b and the CH2Cl2 
molecule in 4b·CH2Cl2 are disordered. Disordered atomic positions were split and refined 
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isotropically using similar distance and similar U restraints and one occupancy parameter per 
disordered group.  
Table 1 
Crystal data and experimental details. 
Complex trans-2b 4b·CH2Cl2 5a 6b·0.5CH2Cl2 8·CH2Cl2 
Formula C16H16Fe2N2O2S C24H24Cl2N2O3Ru2 C22H22Fe2N4O2 
C21.5H23ClFe2N
4O6 
C26H25Cl2Fe2N5
O2 
Fw 412.07 661.49 486.14 580.59 622.11 
T, K 293(2) 293(2) 293(2) 293(2) 100(2) 
λ, Å 0.71073 0.71073 0.71073 0.71073 0.71073 
Crystal system Orthorhombic Monoclinic Monoclinic Triclinic Monoclinic 
Space group Pbca P21/n P21/c P1 P21/n 
a, Å 13.5828(5) 13.112(3) 9.0971(4) 9.0434(18) 13.370(3) 
b, Å 14.7056(6) 13.975(3) 12.1634(5) 14.838(3) 12.149(2) 
c, Å 16.8850(7) 13.879(3) 18.6203(8) 18.788(4) 16.050(3) 
α, ° 90 90 90 81.12(3) 90 
β, ° 90 93.31(3) 93.5230(10) 86.34(3) 96.04(3) 
γ, ° 90 90 90 73.67(3) 90 
Cell Volume, 
Å3 
3372.7(2) 2538.9(9) 2056.47(15) 2389.8(8) 2592.6(9) 
Z 8 4 4 4 4 
Dc, g cm
-3 1.623 1.731 1.570 1.614 1.594 
µ, mm-1 1.853 1.428 1.437 1.371 1.360 
F(000) 1680 1312 1000 1188 1272 
Crystal size, 
mm 
0.25x0.22x0.14 0.27x0.23x 0.16 0.36x0.28x0.16 0.24x0.29x0.13 0.36x0.27x0.18 
θ limits, ° 2.37-26.37 2.07-25.02 2.00-27.48 1.10-25.03 1.89-27.10 
Reflections 
collected 
31402 21941 21992 21312 26853 
Independent 
reflections 
3441 [Rint = 
0.0792] 
4487 [Rint = 
0.0560] 
4721 [Rint = 
0.0587] 
8442 [Rint = 
0.0680] 
5716 [Rint = 
0.0662] 
Data / 
restraints / 
3441 / 26 / 206 4487 / 11 / 299 4721 / 0 / 274 
8442 / 159 / 
630 
5716 / 1 / 337 
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parameters 
Goodness on 
fit on F2 
1.050 1.055 1.053 0.930 1.063 
R1 (I > 2σ(I)) 0.0475 0.0427 0.0429 0.0520 0.0454 
WR2 (all 
data) 
0.1402 0.1237 0.1169 0.1302 0.1193 
Largest diff. 
peak and hole, 
e Å-3 
0.755 / -0.600 1.076 / -0.793 0.457 / -0.340 0.603 / -0.482 0.855 / -0.649 
 
 
3. Results and Discussion 
 
 The MeCN ligand in the µ-aminocarbyne complexes [Fe2{µ-CN(Me)(R)}(µ-
CO)(CO)(MeCN)(Cp)2][SO3CF3] (R= Xyl, 1a; Me, 1b) is almost quantitatively replaced by NCS
- 
after stirring 1 in THF for 3 hours in the presence of an excess of [NBu4][SCN] (Scheme 1). The 
new complexes trans-[Fe2{µ-CN(Me)(R)}(µ-CO)(CO)(NCS)(Cp)2] (R= Xyl, trans-2a; Me, trans-
2b) are, hence, obtained in good yields (71-76 %) after column chromatography, and they have 
been fully characterised by IR and NMR spectroscopy.  
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The molecular structure of trans-2b has been, also, determined by X-ray crystallography 
(Figure 1 and Table 2). The Cp ligands adopt a trans geometry relative to the mean plane 
determined by the Fe2(µ-C)2 core. This is quite unusual, since most of the structures reported for 
diiron complexes containing a bridging aminocarbyne ligand show a cis geometry of the Cp ligands 
[8-10]. The C(13)-N(1) interaction [1.297(5) Å] exhibits a considerably double bond character, 
suggesting that the µ-aminocarbyne ligand can be alternatively described as a µ-iminium ligand. 
The Fe(1)-N(2) interaction [1.932(3) Å] indicates a π-contribution to the bond; in agreement with 
this, the Fe(1)-N(2)-C(16)-S(1) unit is almost linear [bond angles Fe(1)-N(2)-C(16) 169.7(3) and 
N(2)-C(16)-S(1) 178.4(4)°] and N(2) and C(16) exhibit an almost perfect sp hybridisation. This 
linear arrangement of the atoms perfectly agrees with a N-coordinated NCS- ligand [16]. 
Interestingly, the mononuclear complex [Fe(Cp)(CO)2(NCS)] exists in both the N- and S-bonded 
isomeric forms [17], where the N-bonded isomer is the thermodynamically more stable. The NMR 
data for trans-2a,b show the presence in solution of only one species, indicating the complete 
absence of linkage isomerism.  
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Figure 1 
Molecular structure of trans-2b, with key atoms labelled (all H atoms have been omitted). 
Displacement ellipsoids are at 30% probability level. 
 
Table 2 
Selected bond lengths (Å) and angles (°) for complex trans-2b. 
Fe(1)-Fe(2) 2.518(1) Fe(1)-N(2) 1.932(3) 
Fe(2)-C(11) 1.754(5) N(2)-C(16) 1.151(5) 
Fe(1)-C(12) 1.880(4) C(16)-S(1) 1.622(4) 
Fe(2)-C(12) 1.974(5) C(11)-O(11) 1.148(6) 
Fe(1)-C(13) 1.855(4) C(12)-O12) 1.170(5) 
Fe(2)-C(13) 1.874(4) C(13)-N(1) 1.297(5) 
    
Fe(1)-C(12)-Fe(2) 81.55(18) Fe(1)-N(2)-C(16) 169.7(3) 
Fe(1)-C(13)-Fe(2) 84.96(17) N(2)-C(16)-S(1) 178.4(4) 
 
 Complexes trans-2a,b are completely converted into cis-[Fe2{µ-CN(Me)(R)}(µ-
CO)(CO)(NCS)(Cp)2] (R= Xyl, cis-2a; Me, cis-2b) after heating at reflux temperature in THF 
solution for 5 hours (Scheme 1). The isomerisation is clearly indicated by a shift of ca. 20 cm-1 
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toward higher frequencies of the terminal ν(CO), whereas the other IR bands remain nearly 
unchanged. Also the NMR data for trans-2 and cis-2 are very similar as expected since they differ 
only for the relative position of the Cp ligands. The different arrangement of the Cp has been further 
supported by NOE studies; thus, NOE is mutually generated between the two Cp ligans in cis-2 but 
not in trans-2. Complexes cis-2 can be directly obtained from 1 by heating at reflux the latter in the 
presence of NCS-. 
Complex cis-2a reacts with CF3SO3Me to give cis-[Fe2{µ-CN(Me)(Xyl)}(µ-
CO)(CO)(NCSMe)(Cp)2][CF3SO3], 3 (Scheme 2), as clearly indicated by the spectroscopic data 
(see Experimental). Addition of lithium acetylides LiCCR (R= Me, Tol) to 3 results in the 
elimination of S(Me)(CCR) with consequent formation of the known compound cis-[Fe2{µ-
CN(Me)(Xyl)}(µ-CO)(CO)(CN)(Cp)2], in about 80 % yield [9b].  
 
Scheme 2 
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 Similarly to what reported for the preparation of 2, the complexes cis-[M2{µ-
CN(Me)(R)}(µ-CO)(CO)(NCO)(Cp)2] (M = Fe, R= Me, 4a; M = Ru, R = Xyl, 4b; M = Ru, R = 
Me, 4c) and cis-[M2{µ-CN(Me)(R)}(µ-CO)(CO)(N3)(Cp)2]  (M = Fe, R= Xyl, 5a; M = Fe, R = 
Me, 5b; M = Ru, R = Xyl, 5c) are obtained by heating at reflux temperature [M2{µ-CN(Me)(R)}(µ-
CO)(CO)(MeCN)(Cp)2][SO3CF3] (M = Fe, R= Xyl, 1a; M = Fe, Me, 1b; M = Ru, R = Xyl, 1c; M = 
Ru, R = Me, 1d) in THF in the presence of NaNCO and NaN3, respectively (Scheme 3). Complexes 
4-5 are obtained in good yields (65-76 %) after column chromatography.  
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The molecular structures of 4b and 5a are reported in Figures 2 and 3, whereas the main 
bond lengths and bond angles are reported in Tables 3 and 4. The Cp ligands show in both the 
molecules a cis arrangement relative to the M2(µ-C)2 core; moreover, the Xyl substituents in the µ-
CN(Me)(Xyl) ligand points towards the terminal CO in both 4b and 5a, as previously found in 
analogous diiron and diruthenium complexes [10c, 18]. The metal-isocyanate linkage in 4b is 
approximately linear [bond angles Ru(1)-N(2)-C(23) 167.0(5) and N(2)-C(23)-O(2) 177.8(8)°], and 
the C(23)-N(2) distance [1.138(8) Å] is significantly shorter than C(23)-O(2) [1.213(8) Å], 
implying some triple bond character for the former. This is a clear indication of the N-coordination 
of the NCO- ligand, as previously demonstrated in complexes such as [Cr(Cp)(NCO)(NO)2] [19] 
and [M(Cp)2(NCO)2] (M = Ti, Zr) [5]. Conversely, the azido ligand in 5a shows a bent coordination 
[bond angle Fe(1)-N(2)-N(3) 120.1(3)°] and the Fe(1)-N(2) distance [2.009(3) Å] is characteristic 
for a σ-interaction, as found in the analogous amino complex [Fe2{µ-CN(Me)2}(µ-
CO)(CO)(EtNH2)(Cp)2][SO3CF3] [Fe-N 2.018(9) Å] [18].  
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Figure 2 
Molecular structure of 4b, with key atoms labelled (all H atoms have been omitted). Displacement 
ellipsoids are at 30% probability level. 
 
Table 3 
Selected bond lengths (Å) and angles (°) for complex 4b.  
Ru(1)-Ru(2) 2.7005(8) Ru(1)-N(2) 2.088(5) 
Ru(2)-C(11) 1.850(6) N(2)-C(23) 1.138(8) 
Ru(1)-C(12) 1.981(6) C(23)-O(2) 1.213(8) 
Ru(2)-C(12) 2.108(5) C(11)-O(11) 1.143(7) 
Ru(1)-C(13) 1.940(5) C(12)-O12) 1.166(7) 
Ru(2)-C(13) 1.991(5) C(13)-N(1) 1.304(6) 
    
Fe(1)-C(12)-Fe(2) 82.6(2) Fe(1)-N(2)-C(16) 167.0(35) 
Fe(1)-C(13)-Fe(2) 86.8(2) N(2)-C(16)-S(1) 177.8(8) 
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Figure 3 
Molecular structure of 5a, with key atoms labelled (all H atoms have been omitted). Displacement 
ellipsoids are at 30% probability level. 
 
Table 4 
Selected bond lengths (Å) and angles (°) for complex 5a.  
Fe(1)-Fe(2) 2.4999(6) Fe(1)-N(2) 2.009(3) 
Fe(2)-C(11) 1.753(4) N(2)-N(3) 1.187(4) 
Fe(1)-C(12) 1.882(3) N(3)-N(4) 1.161(5) 
Fe(2)-C(12) 1.968(3) C(11)-O(11) 1.143(4) 
Fe(1)-C(13) 1.849(3) C(12)-O12) 1.173(4) 
Fe(2)-C(13) 1.877(3) C(13)-N(1) 1.304(4) 
    
Fe(1)-C(12)-Fe(2) 80.94(14) Fe(1)-N(2)-C(16) 120.1(3) 
Fe(1)-C(13)-Fe(2) 84.29(13) N(2)-C(16)-S(1) 176.8(5) 
 
 The IR spectra of 4-5 show ν(CO) for the terminal and bridging carbonyls at ca. 1980 and 
1800 cm-1, respectively; the former data well agrees with a cis geometry of the Cp ligands also in 
solution. Moreover, complexes 4 show ν(NCO) at ca. 2235 cm-1, whereas ν(N3) in 5 absorbs at ca. 
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2030 cm-1. The NMR spectra of 4-5 show the presence in solution of a single species, except for 5a 
where a second isomer is present (major : minor = 10). This is probably due to a different 
orientation of the Me and Xyl substituents on the µ-CN(Me)(Xyl) ligand (Scheme 4), as previously 
found in analogous diiron and diruthenium µ-aminocarbyne complexes [10c, 18]. The most 
important feature of the 13C NMR spectra is the presence of three resonances at low fields 
attributable to the µ-aminocarbyne carbon (δ ca. 340 ppm M=Fe; 310 ppm M=Ru), the µ-CO (δ ca. 
266 ppm M=Fe; 236 ppm M=Ru) and the terminal CO ligand (δ ca. 211 ppm M=Fe; 200 ppm 
M=Ru). The carbon of the NCO ligand in 4 resonates at ca. 128 ppm as expected for isocyanate 
ligands.  
Scheme 4 
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 The azido complexes 5 react in THF solution at reflux with electron poor alkynes such as 
MeO2CC≡CCO2Me and HC≡CCO2Me affording the triazolato complexes [M2{µ-CN(Me)(R)}(µ-
CO)(CO){N3C2(CO2Me)2}(Cp)2] (M = Fe, R= Xyl, 6a; M = Fe, R = Me, 6b; M = Ru, R = Xyl, 6c) 
and [M2{µ-CN(Me)(R)}(µ-CO)(CO){N3C2(H)(CO2Me)}(Cp)2] (M = Fe, R= Me, 7a; M = Ru, R = 
Xyl, 7b) (Scheme 5). In a similar fashion, the reaction of 5a with fumaronitrile 
(NC)(H)C=C(H)(CN) under analogous conditions affords the triazolato product [Fe2{µ-
CN(Me)(Xyl)}(µ-CO)(CO){N3C2(H)(CN)}(Cp)2], 8. All these products have been obtained in good 
yields (70-90 %) after column chromatography and fully characterised spectroscopically via IR and 
NMR. Moreover, the molecular structures of 6b and 8 have been determined by X-ray diffraction 
studies (Figures 4 and 5, and Tables 5 and 6). The formation of 6-8 proceeds via [3+2] 
cycloaddition of the alkyne or the alkene, as previously demonstrated for mononuclear azido 
complexes [7, 20]; in the case of 8, the reaction is accompanied by loss of HCN.  
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Figure 4 
Molecular structure of 6b, with key atoms labelled (all H atoms have been omitted). Displacement 
ellipsoids are at 30% probability level. Only one of the two independent molecules is represented.  
 
 
Table 5 
Selected bond lengths (Å) and angles (°) for the two independent molecules of complex 6b.  
Fe(1)-Fe(2) 2.5200(11) Fe(3)-Fe(4) 2.5062(11) 
Fe(2)-C(11) 1.753(5) Fe(4)-C(41) 1.755(6) 
Fe(1)-C(12) 1.881(5) Fe(3)-C(42) 1.861(5) 
Fe(2)-C(12) 1.968(5) Fe(4)-C(42) 1.969(5) 
Fe(1)-C(13) 1.842(5) Fe(3)-C(43) 1.845(5) 
Fe(2)-C(13) 1.885(4) Fe(4)-C(43) 1.877(5) 
Fe(1)-N(2) 1.998(4) Fe(3)-N(6) 1.989(4) 
N(2)-N(3) 1.318(5) N(6)-N(7) 1.315(5) 
N(2)-N(4) 1.330(5) N(6)-N(8) 1.320(5) 
N(3)-C(16) 1.362(6) N(7)-C(46) 1.369(6) 
N(4)-C(17) 1.347(6) N(8)-C(47) 1.354(6) 
 21 
C(16)-C(17) 1.391(6) C(46)-C(47) 1.383(6) 
C(11)-O(11) 1.149(6) C(41)-O(41) 1.141(5) 
C(12)-O(12) 1.176(5) C(42)-O(42) 1.178(5) 
C(13)-N(1) 1.305(5) C(43)-N(5) 1.307(6) 
    
Fe(1)-C(12)-Fe(2) 81.77(19) Fe(3)-C(42)-Fe(4) 81.7(2) 
Fe(1)-C(13)-Fe(2) 85.06(19) Fe(3)-C(43)-Fe(4) 84.6(2) 
Fe(1)-N(2)-N(3) 123.0(3) Fe(3)-N(6)-N(7) 124.8(3) 
N(2)-N(3)-C(16) 105.0(4) N(6)-N(7)-C(46) 104.9(4) 
N(3)-C(16)-C(17) 107.3(4) N(7)-C(46)-C(47) 107.3(4) 
C(16)-C(17)-N(4) 108.5(4) C(46)-C(47)-N(8) 108.3(4) 
C(17)-N(4)-N(2) 104.7(4) C(47)-N(8)-N(6) 104.8(4) 
 
 
Figure 5 
Molecular structure of 8, with key atoms labelled (all H atoms, except H23, have been omitted). 
Displacement ellipsoids are at 30% probability level. 
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Table 6 
Selected bond lengths (Å) and angles (°) for complex 8.  
Fe(1)-Fe(2) 2.5084(8)   
Fe(2)-C(11) 1.760(3) N(2)-N(3) 1.351(2) 
Fe(1)-C(12) 1.880(3) N(3)-N(4) 1.326(4) 
Fe(2)-C(12) 1.977(3) N(4)-C(24) 1.336(4) 
Fe(1)-C(13) 1.863(2) C(23)-C(24) 1.377(4) 
Fe(2)-C(13) 1.892(2) C(24)-C(25) 1.432(4) 
Fe(1)-N(2) 1.970(2) C(25)-N(5) 1.151(4) 
C(11)-O(11) 1.150(3) C(13)-N(1) 1.305(3) 
C(12)-O(12) 1.179(3) C(14)-N(1) 1.481(3) 
    
Fe(1)-C(12)-Fe(2) 81.10(10) N(3)-N(4)-C(24) 107.1(2) 
Fe(1)-C(13)-Fe(2) 83.83(10) N(4)-C(24)-C(23) 108.8(2) 
Fe(1)-N(2)-N(3) 122.66(18) C(24)-C(23)-N(2) 106.7(2) 
N(2)-N(3)-N(4) 110.0(2) C(24)-C(25)-N(5) 176.9(4) 
 
 The asymmetric unit of 6b contains two independent molecules, with similar relative 
arrangement of the atoms, similar bond lengths and bond angles but opposite absolute structure. The 
molecular structures of 6b and 8 exhibit a cis arrangement of the Cp ligands; moreover, in the case 
of 8 where the bridging aminocarbyne ligand is asymmetrically substituted, the bulkier Xyl group 
points in the direction of the terminal CO ligand. The triazolato ligand is N(2) coordinated in 6b, 
whereas it is bound to iron via N(1) in 8. Both these coordination modes of the triazolato ligand 
have been previously reported [20a]; molecular orbital calculations [21] indicate that these two 
bonding modes are essentially isoenergetic. Evidence obtained to date indicates that either two 
isomers N(1) and N(2) are formed simultaneously or only the N(2) isomer is produced exclusively 
[7, 20c, 22]. Our work completely support this hypothesis; in fact, in the case of complexes 6 which 
contain a symmetrically disubstituted triazolato ligand N3C2(CO2Me)2, only the N(2)-bound isomer 
is formed as shown by NMR data. Conversely, the complexes 7-8, which posses a monosubstituted 
triazolato ligand, are formed as a mixture of N(1) and N(2) isomers (Scheme 6). 
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 The IR spectra for 6-8 show two ν(CO) at frequencies similar to the starting azido 
complexes 5, indicating a similar electronic character of the two ligands. As a consequence of the 
symmetrical N(2) coordination, the carbon atoms of the triazolato ligand and the two COOMe 
substituents in 6 are equivalent and give rise to single NMR resonances [e.g. δH 3.7-3.8 ppm for 
CO2Me; δC ca. 162, 140 and 52 ppm for N3C2(CO2Me)2, N3C2(CO2Me)2 and N3C2(CO2Me)2, 
respectively]. Conversely, for 7-8 two sets of resonances are present for the N(2) and N(1) isomers 
[N(2) : N(1) isomer ratio = 1.1-2 : 1]. NOE studies clearly indicate that the major isomer is the 
N(1)-bound, which is the one also present in the solid state for 8. For instance, irradiation of the 
triazolato proton (δH 7.74 ppm) in the major isomer of 8 produces a strong enhancement of the 
resonance of one Cp ligand, whereas no effect is observed after irradiation of the corresponding 
resonance in the minor isomer (δH 7.46 ppm).  
 The triazolato complexes 6-7 react in CH2Cl2 solution with CF3SO3Me affording the N-
methylated cationic complexes [Fe2{µ-CN(Me)(Xyl)}(µ-
CO)(CO){N3(Me)C2(CO2Me)2}(Cp)2][CF3SO3], 9, and [M2{µ-CN(Me)(R)}(µ-
CO)(CO){N3(Me)C2(H)(CO2Me)}(Cp)2][CF3SO3] (M = Fe, R = Me, 10a; M = Ru, R = Xyl, 10b), 
in good yields (90-95 %) (Scheme 7).  
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Their NMR spectra show the presence in solution of a single species; NOE experiments on 
10b clearly indicate a strong interaction between one Cp ligand and the CH proton of the triazole 
ring, suggesting that methylation occurs selectively at N(3) and the triazole is N(1) coordinated. It is 
interesting to notice that in previous works [7] a similar regiochemistry for the methylation process 
was observed, but it was, then, followed by the release of the triazole molecule. Conversely, in our 
case the complexes 9-10 are stable in solution and do not lose the heterocycle ligand. In a similar 
way, the methylation of 8 results in the nearly quantitative formation of the complex [Fe2{µ-
CN(Me)(Xyl)}(µ-CO)(CO){N3(Me)C2(H)(CN)}(Cp)2][CF3SO3], 11. The IR spectrum shows the 
usual ν(CO) for the terminal and bridging carbonyls at frequencies similar to those observed for 9-
10, and ν(CN) at 2220 cm-1; hence, also in this case methylation has occurred on the triazolato ring. 
The NMR spectra show the presence of two isomers in a 1.2:1 ratio and with very similar but 
distinct resonances. This can be explained assuming that the methylation of 8 is not regioselective, 
but it can occur on both N(1) and N(3) (Scheme 8).  
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4. Conclusions 
 
 This study shows that dimetallic aminocarbyne complexes containing pseudohalide ligands 
can be obtained by MeCN displacement from [M2{µ-CN(Me)(R)}(µ-
CO)(CO)(MeCN)(Cp)2][SO3CF3] (M = Fe, R= Xyl, 1a; M = Fe, Me, 1b; M = Ru, R = Xyl, 1c; M = 
Ru, R = Me, 1d). We had previously shown that nitrile substitution in 1 could be used also for the 
introduction of other N-donor ligands, such as amines and imines [18]. All these reactions are 
completely selective, and no product of addition of the N-nucleophile has been observed during our 
work, even though nucleophilic additions to coordinated nitriles have been widely documented in 
the literature [23]. Probably, the MeCN ligand in 1 is not sufficiently activated to react with N-
nucleophiles, whereas it reacts easily with C-nucleophiles [9a, 9c, 10c].  
 The results reported in this paper suggest that nitrile substitution in 1 proceeds with 
inversion of the configuration of the metal-centre and, in fact, the products obtained at room 
temperature present a trans geometry of the Cp ligands, whereas the parent complexes 1 have a cis 
structure. Moreover, trans to cis isomerisation occurs at high temperature, indicating that the trans 
isomer is the kinetic product whereas the cis species is the thermodynamic one, as previously found 
for the vinyliminium complexes [Fe2{µ-σ:η
3-C(R')=C(R’’)C=N(Me)(R)}(µ-
CO)(CO)(Cp)2][SO3CF3] [10a, 10b].  
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5. Supplementary material 
 
Crystallographic data for the structural analyses have been deposited with the Cambridge 
Crystallographic Data Centre, CCDC Nos. 253688 for trans-2b, 253689 for 4b·CH2Cl2, 253690 for 
5a, 253691 for 6b·0.5CH2Cl2 and 253692 for 8·CH2Cl2. Copies of this information can be obtained 
free of charge from the Director, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44-
1233-336033; e-mail: deposit@ccdc.cam.ac.uk or http://www.ccdc.cam.ac.uk). 
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Graphical abstract 
 
 
Diiron and diruthenium aminocarbyne complexes containing pseudohalide ligands (i.e. 
NCS-, NCO-, N3
-) have been obtained by nitrile replacement; both cis and trans isomers can be 
formed depending on the reaction temperature and trans to cis isomerisation is observed at high 
temperature. The terminal azido ligand undergoes 1,3-dipolar cycloaddition reactions with alkynes 
and fumaronitrile, affording new dinuclear triazolato complexes.  
 
 
 
